Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.
about
An increased total resected lymph node count benefits survival following pancreas invasive intraductal papillary mucinous neoplasms resection: an analysis using the surveillance, epidemiology, and end result registry databaseNatural History and Management of Intraductal Papillary Mucinous Neoplasms: Current EvidenceScreening for pancreatic cancer in familial high-risk individuals: A systematic reviewMultidisciplinary diagnostic and therapeutic approaches to pancreatic cystic lesionsOverview of the investigation and management of cystic neoplasms of the pancreasPancreatic cystic neoplasms: Review of current knowledge, diagnostic challenges, and management optionsExtent of Surgery and Implications of Transection Margin Status after Resection of IPMNsIntraductal papillary mucinous neoplasm (IPMN) with extra-pancreatic mucin: a case series and review of the literatureIntraductal Papillary Mucinous Neoplasm of PancreasA Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the PancreasIntraductal Papillary Mucinous Neoplasm of the Pancreas: Current PerspectivesCystic neoplasms of the pancreas.Plectin-1 is a biomarker of malignant pancreatic intraductal papillary mucinous neoplasms.Imaging of benign and malignant cystic pancreatic lesions and a strategy for follow upFrequent detection of pancreatic lesions in asymptomatic high-risk individuals.Intraductal papillary mucinous neoplasms of the pancreas: is the puzzle solved?Pancreatic cystic lesions: clinical predictors of malignancy in patients undergoing surgery.High-throughput mutation profiling in intraductal papillary mucinous neoplasm (IPMN).Prognosis of cancer with branch duct type IPMN of the pancreas.Intraductal papillary mucinous neoplasm of the pancreas (IPMN): clinico-pathological correlations and surgical indicationsLess common neoplasms of the pancreas.Consensus guidelines in the management of branch duct intraductal papillary mucinous neoplasm: a cost-effectiveness analysisIn vivo and in vitro propagation of intraductal papillary mucinous neoplasms.Pancreatic cyst prevalence and the risk of mucin-producing adenocarcinoma in US adults.Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma: a stage-matched comparison of outcomes.EZH2 is associated with malignant behavior in pancreatic IPMN via p27Kip1 downregulation.Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation.Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreasThe utilization of imaging features in the management of intraductal papillary mucinous neoplasms.Pathological features and diagnosis of intraductal papillary mucinous neoplasm of the pancreas.Extrapancreatic malignancies and intraductal papillary mucinous neoplasms of the pancreasPopulation-based epidemiology, risk factors and screening of intraductal papillary mucinous neoplasm patients.Differences between main-duct and branch-duct intraductal papillary mucinous neoplasms of the pancreasThe good, the bad and the ugly: a tale of miR-101, miR-21 and miR-155 in pancreatic intraductal papillary mucinous neoplasms.International Consensus Guidelines parameters for the prediction of malignancy in intraductal papillary mucinous neoplasm are not properly weighted and are not cumulative.Intraductal papillary mucinous neoplasm of the pancreas: an updateNovel xenograft and cell line derived from an invasive intraductal papillary mucinous neoplasm of the pancreas give new insights into molecular mechanisms.Current recommendations for surveillance and surgery of intraductal papillary mucinous neoplasms may overlook some patients with cancerDetermination of malignant and invasive predictors in branch duct type intraductal papillary mucinous neoplasms of the pancreas: a suggested scoring formulaScreening for pancreatic cancer: current evidence and future directions.
P2860
Q21131945-0086C8E5-1C6E-4468-B396-7A21F042B136Q26796500-9769F826-9BD5-4467-BD10-444B6CE81054Q26801172-8F7E596C-C347-4D0E-A35E-9D3415B98C73Q26829835-2676281F-14D8-4C75-9FBD-25B1C0AB5B4FQ26864865-57794B11-261E-4C52-8698-80A0E3B29149Q26865466-CEB085A4-8FF8-4983-8B99-D2BAB593F02FQ26991981-0A37A368-3E12-4BB1-B868-B215827C2DE4Q26996721-7876C525-A381-4E7C-A44A-3A085E053170Q27028114-4147AB1A-CFDA-4DBC-A7CF-2C21B7ECC66CQ28082890-49AB05AC-A3BA-465A-AA1D-ABA503C17F95Q28087395-37D5C5B2-2AD6-411C-B008-9A49AE7636BDQ30415099-1304EE75-473A-409B-BDDD-67C05E9A7619Q30416761-9614D88D-70C4-4C51-A172-9B8F5DD51F48Q30478145-48CF2A67-AA87-46C0-A6D4-E4A287AF6823Q30512754-13ECB96E-B082-4921-B06B-4E78AB15FB73Q33355493-0324F01A-06BD-4181-8181-9F0B1A312FB6Q33596302-699FABE3-E73D-4CBF-8C14-A1343B81FA49Q33790925-4C9FCAC3-4E83-4923-9D8D-A1978C2F94EEQ33798891-67E0196D-750C-4C80-B7EE-9BF1D3DF42E6Q33806809-C92B0D7C-82D5-47E9-8F2E-ACDC4BA26D2EQ33868386-BEAD32C9-D360-499C-8341-47FA1774B36BQ33871791-AF2C9D08-238A-444D-86EB-38272A6D59B4Q33911620-A16A902D-0AC2-40F6-A049-D6C17FCF7A6DQ33970217-BDFF36F9-728D-4988-B7F1-1FCD97974F54Q33987127-9F137965-3DB7-41F1-ABB9-00F386E7848AQ33988909-3306F5B3-D64F-4788-A7E1-371A0128C3FCQ33991839-BAB6D15C-9D3D-44CF-8B1D-F105BCE77293Q34100230-2DE2DAE8-E6BE-4639-A7E6-30FCF3413761Q34118820-2F8FD175-C761-485E-AC2E-622817E704F4Q34179171-3BD7EDA8-57A5-47B9-A603-C8B9FFFF0297Q34391281-3656B39F-FEA7-40F1-A9D4-7C3E5FC52DC2Q34391289-D016BFE0-613E-462A-B579-EFBC6AA3F4DAQ34391306-91169986-6602-4313-9146-3C1BD866D80CQ34471577-B3AA8BF6-45B8-4499-B1E1-ADA3E0FB3124Q34548931-052637F5-30BC-4D95-B3D2-54F22F6B428FQ34657866-AFEDD828-386C-4CAF-AEAF-276EC9EE26ABQ34909909-23894ED8-44F4-4B9F-ABA2-585D1C44D6A0Q35009641-90367552-161D-4912-9EC6-36F3E30B78DEQ35009837-C08F7073-686C-4F84-959B-C75F6D9A66F8Q35014007-06915B4A-C98C-479B-80B1-8B587B089AB2
P2860
Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Main-duct intraductal papillar ...... survival following resection.
@en
Main-duct intraductal papillar ...... survival following resection.
@nl
type
label
Main-duct intraductal papillar ...... survival following resection.
@en
Main-duct intraductal papillar ...... survival following resection.
@nl
prefLabel
Main-duct intraductal papillar ...... survival following resection.
@en
Main-duct intraductal papillar ...... survival following resection.
@nl
P2093
P1433
P1476
Main-duct intraductal papillar ...... survival following resection.
@en
P2093
Andrew L Warshaw
Carlos Fernández-del Castillo
Claudio Bassi
Paolo Pederzoli
Sarah P Thayer
William Mantovani
P304
678-85; discussion 685-7
P356
10.1097/01.SLA.0000124386.54496.15
P407
P577
2004-05-01T00:00:00Z